These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 23188792)
21. In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene. Arhin FF; Sarmiento I; Moeck G Int J Antimicrob Agents; 2014 Jul; 44(1):65-8. PubMed ID: 24906505 [TBL] [Abstract][Full Text] [Related]
22. Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro. Sandberg A; Jensen KS; Baudoux P; Van Bambeke F; Tulkens PM; Frimodt-Møller N J Antimicrob Chemother; 2010 May; 65(5):962-73. PubMed ID: 20211859 [TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers. Sader HS; Farrell DJ; Flamm RK; Jones RN Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170 [TBL] [Abstract][Full Text] [Related]
24. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. LaPlante KL; Rybak MJ Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic model. Steed M; Vidaillac C; Rybak MJ Antimicrob Agents Chemother; 2011 Jul; 55(7):3522-6. PubMed ID: 21576449 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp. Gil Romero Y; Gómez-Garcés JL Enferm Infecc Microbiol Clin (Engl Ed); 2020 Jan; 38(1):25-27. PubMed ID: 31072712 [TBL] [Abstract][Full Text] [Related]
27. In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure. Bhalodi AA; Hagihara M; Nicolau DP; Kuti JL Antimicrob Agents Chemother; 2014; 58(2):672-7. PubMed ID: 24217694 [TBL] [Abstract][Full Text] [Related]
28. Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014. Fang H; Fröding I; Gian B; Hæggman S; Tollström UB; Ullberg M; Nord CE J Glob Antimicrob Resist; 2016 Jun; 5():31-5. PubMed ID: 27436463 [TBL] [Abstract][Full Text] [Related]
29. In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus. García AB; Candel FJ; López L; Chiarella F; Viñuela-Prieto JM J Med Microbiol; 2016 Oct; 65(10):1119-1122. PubMed ID: 27553740 [TBL] [Abstract][Full Text] [Related]
30. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus. Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792 [TBL] [Abstract][Full Text] [Related]
31. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus. Salem AH; Zhanel GG; Ibrahim SA; Noreddin AM Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections. Hodille E; Delouere L; Bouveyron C; Meugnier H; Bes M; Tristan A; Laurent F; Vandenesch F; Lina G; Dumitrescu O Med Mal Infect; 2017 Mar; 47(2):152-157. PubMed ID: 27856079 [TBL] [Abstract][Full Text] [Related]
33. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Sader HS; Fritsche TR; Jones RN Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409 [TBL] [Abstract][Full Text] [Related]
34. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
36. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746 [TBL] [Abstract][Full Text] [Related]
37. Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia. Espedido BA; Jensen SO; van Hal SJ J Antimicrob Chemother; 2015 Mar; 70(3):797-801. PubMed ID: 25406295 [TBL] [Abstract][Full Text] [Related]
38. [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods]. Gómez-Garcés JL; López-Fabal F; Burillo A; Gil Y Rev Esp Quimioter; 2010 Jun; 23(2):87-92. PubMed ID: 20559607 [TBL] [Abstract][Full Text] [Related]